[Federal Register Volume 73, Number 145 (Monday, July 28, 2008)]
[Notices]
[Page 43764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-17245]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Synthesis of Stable Isotope-Labeled Steroids as Internal 
Standards for the Measurement of Endogenous Steroid Hormones in 
Biologic Samples by Liquid Chromatography.
    Date: August 26, 2008.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6130 Executive Boulevard, 
Conference Room 319, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Kenneth L. Bielat, PhD, Scientific Review 
Officer, Special Review Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7147, Bethesda, MD 20892-8329, 301-496-7576, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Altered Isoflavone Soybeans for Hormone-Responsive Cancer.
    Date: September 8, 2008.
    Time: 12:30 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 607, Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Marvin L. Salin, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7073, Bethesda, MD 20892-8329, 301-496-0694, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Breast, Brain, GI, HN, Ovarian, and Pancreatic 
Cancers.
    Date: September 24-25, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Shamala K. Srinivas, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8123, Bethesda, MD 20892, 301-594-1224, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Discovery and Development.
    Date: October 1-2, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, Double Tree Name Changed, 
1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: Caron Lyman, PhD, Scientific Review Officer, 
Division of Extramural Activities, National Cancer Institute, 
National Institutes of Health, 6116 Executive Blvd, Room 8119, 
Bethesda, MD 20892-8328, 301-451-4761, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Studies I P01.
    Date: October 6-7, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville Executive Mtg Center, 1750 
Rockville Pike, Rockville, MD 20852.
    Contact Person: Majed M. Hamawy, PhD, MBA, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 8135, Bethesda, MD 20892-8328, 301-594-5659, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Studies II P01.
    Date: October 7, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, Double Tree Name Changed, 
1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: Peter J. Wirth, PhD, Scientific Review Officer, 
Research Programs Review Branch, Division of Extramural Activities, 
National Cancer Institute, 6116 Executive Boulevard, Room 8131, 
Bethesda, MD 20892-8328, 301-496-7565, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Prevention, Control and Population Sciences.
    Date: October 7-8, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, Double Tree Name Changed, 
1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: Wlodek Lopaczynski, MD, PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Blvd., Room 
8131, Bethesda, MD 20892, 301-594-1402, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: July 22, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-17245 Filed 7-25-08; 8:45 am]
BILLING CODE 4140-01-P